(Reference is made to the Company’s announcements dated 17 December 2024, 13 January 2025, 10 March 2025, 28 March 2025, 11 April 2025 and 24 June 2025 in relation to the Proposals (“Announcements”). All abbreviations and definitions used herein shall have the same meanings as the words and expressions defined in the Announcements.)

On behalf of the Board, Maybank IB wishes to announce that the Board has on 11 July 2025 (“Price-Fixing Date”) resolved to fix the issue price of the Rights Shares at RM0.09 per Rights Share (“Issue Price”) and exercise price of the Warrants at RM0.11 per Warrant (“Exercise Price”).

The Issue Price was determined and fixed by the Board (save for LCS, being an interested director of Parkwood) after taking into consideration, among others, the following:

(a) the TERP of Parkwood Shares based on the 5D-VWAP of Parkwood Shares up to and including 10 July 2025, being the last market day immediately preceding the Price-Fixing Date, and the Board’s intention to fix the Issue Price at a discount of not more than 20.0% to the TERP of Parkwood Shares.

The Issue Price of RM0.09 per Rights Share represents a discount of approximately 0.55% to the TERP of Parkwood Shares of RM0.0905. The TERP was computed based on the 5D-VWAP of Parkwood Shares up to and including 10 July 2025, being the last market day immediately preceding the Price-Fixing Date, of RM0.0916 per Parkwood Share;

(b) the prevailing market conditions; and

(c) the prevailing market price of Parkwood Shares.

The Exercise Price was determined and fixed by the Board (save for LCS, being an interested director of Parkwood) after taking into consideration, among others, the following:

(a) the TERP of Parkwood Shares based on the 5D-VWAP of Parkwood Shares up to and including 10 July 2025, being the last market day immediately preceding the Price-Fixing Date, and the Board’s intention to fix the Exercise Price at a premium of not more than 20.0% to the TERP of Parkwood Shares;

(b) funding requirements of the Group and timing of such funding requirements;

(c) the Board’s intention to incentivise the Entitled Shareholders to subscribe for their entitlements under the Rights Issue with Warrants; and

(d) to reward and provide the Subscribing Shareholders with an option to further increase their equity participation in Parkwood by exercising their Warrants during the Exercise Period.

For avoidance of doubt, the issue price of the RCPS for the Subscription will be determined and announced by the Board at a later date.

This announcement is dated 11 July 2025.